Novel SAPK Activating Kinase in Renal Epithelial Stress

肾上皮应激中的新型 SAPK 激活激酶

基本信息

项目摘要

DESCRIPTION (provided by applicant): Acute renal failure secondary to tubular epithelial ischemic injury is a major cause of patient morbidity. Renal tubular epithelial cell injury results in dramatic cellular phenotypic changes including alterations in morphology and induction of genetic programs thought to be critical for regulating the cell's response to injury. Depending on the type or extent of injury, proximal tubular epithelial cells either sustain sublethal injury and recover, or die and are replaced. Investigating the proximal signaling pathways that regulate these responses should provide better understanding of the complex nature of these responses to injury. Stress activating protein kinases or c-Jun N-terminal kinases (JNK) are rapidly activated by multiple cellular stresses including renal ischemia/reperfusion injury and are implicated in regulating processes as diverse as cell proliferation, apoptosis, and development. We have identified, cloned from embryonic kidney, and initially characterized the protein kinase called DLK. DLK is a MAP kinase kinase kinase of the mixed lineage kinase family (MLK) that may be activated by cellular injury and is capable of activating JNK. In the kidney, DLK is uniquely expressed in the proximal tubular epithelium. Given these observations, we hypothesize that DLK represents a proximal component of a signaling pathway that participates in modulating the response to proximal tubular epithelial injury. In part, MLK-dependent JNK signaling might affect the tubular injury response by regulating Pax2 phosphorylation and activation. Critical for renal epithelial morphogenesis, the transcription factor Pax2 is re-expressed in proximal tubular epithelium following injury and may direct post-injury tubular regeneration. New data suggests that Pax2 transcriptional activity is regulated by JNK-mediated phosphorylation potentially via an MLK-dependent JNK pathway.This proposal seeks primarily to investigate the fundamental biochemistry and regulation of DLK within its JNK signaling complex or module. By using a combination of biochemical approaches and by characterizing a newly prepared DLK null mouse, this project will begin to investigate the role of DLK-dependent signaling in the kidney.
描述(由申请人提供):继发于小管上皮缺血性损伤的急性肾功能衰竭是患者发病的主要原因。肾小管上皮细胞损伤会导致显著的细胞表型改变,包括形态学改变和基因程序的诱导,这些基因程序被认为是调节细胞对损伤反应的关键。根据损伤的类型或程度,近端小管上皮细胞要么维持亚致死损伤并恢复,要么死亡并被替换。研究调节这些反应的近端信号通路可以更好地理解这些损伤反应的复杂性。应激激活蛋白激酶或c-Jun n -末端激酶(JNK)在包括肾缺血/再灌注损伤在内的多种细胞应激下迅速激活,并参与调节细胞增殖、凋亡和发育等多种过程。我们从胚胎肾脏中克隆出一种蛋白激酶,叫做DLK。DLK是混合谱系激酶家族(MLK)的一种MAP激酶激酶,可被细胞损伤激活,并能激活JNK。在肾脏中,DLK仅在近端小管上皮中表达。鉴于这些观察结果,我们假设DLK代表了参与调节近端小管上皮损伤反应的信号通路的近端组成部分。在某种程度上,mlk依赖的JNK信号可能通过调节Pax2的磷酸化和激活来影响小管损伤反应。对肾上皮形态发生至关重要的转录因子Pax2在损伤后近端小管上皮中重新表达,并可能指导损伤后小管再生。新的数据表明,Pax2的转录活性可能通过mlk依赖的JNK途径受到JNK介导的磷酸化的调节。本研究主要旨在研究DLK在其JNK信号复合物或模块中的基本生物化学和调控。通过结合生化方法和表征新制备的DLK缺失小鼠,该项目将开始研究DLK依赖性信号在肾脏中的作用。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAWRENCE B. HOLZMAN其他文献

LAWRENCE B. HOLZMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAWRENCE B. HOLZMAN', 18)}}的其他基金

Primary Outcomes in Glomerulonephritis Study (PROGRESS)
肾小球肾炎研究的主要结果(进展)
  • 批准号:
    9115603
  • 财政年份:
    2013
  • 资助金额:
    $ 30.31万
  • 项目类别:
Primary Outcomes in Glomerulonephritis Study (PROGRESS)
肾小球肾炎研究的主要结果(进展)
  • 批准号:
    8924248
  • 财政年份:
    2013
  • 资助金额:
    $ 30.31万
  • 项目类别:
Primary Outcomes in Glomerulonephritis Study (PROGRESS)
肾小球肾炎研究的主要结果(进展)
  • 批准号:
    8733166
  • 财政年份:
    2013
  • 资助金额:
    $ 30.31万
  • 项目类别:
CureGN-Penn PCC
CureGN-宾夕法尼亚PCC
  • 批准号:
    10414798
  • 财政年份:
    2013
  • 资助金额:
    $ 30.31万
  • 项目类别:
CureGN-Penn PCC
CureGN-宾夕法尼亚PCC
  • 批准号:
    10656280
  • 财政年份:
    2013
  • 资助金额:
    $ 30.31万
  • 项目类别:
Primary Outcomes in Glomerulonephritis Study (PROGRESS)
肾小球肾炎研究的主要结果(进展)
  • 批准号:
    8627364
  • 财政年份:
    2013
  • 资助金额:
    $ 30.31万
  • 项目类别:
Pilot/Feasibility
试点/可行性
  • 批准号:
    10480859
  • 财政年份:
    2009
  • 资助金额:
    $ 30.31万
  • 项目类别:
Career Enhancement
职业提升
  • 批准号:
    10480861
  • 财政年份:
    2009
  • 资助金额:
    $ 30.31万
  • 项目类别:
Career Enhancement
职业提升
  • 批准号:
    10700988
  • 财政年份:
    2009
  • 资助金额:
    $ 30.31万
  • 项目类别:
Slit Diaphragm and Actin Dynamics
狭缝隔膜和肌动蛋白动力学
  • 批准号:
    8060605
  • 财政年份:
    2009
  • 资助金额:
    $ 30.31万
  • 项目类别:

相似海外基金

Elucidation of the Role of Connexin 43 in Ischemic Acute Renal Failure
阐明连接蛋白 43 在缺血性急性肾衰竭中的作用
  • 批准号:
    19K08684
  • 财政年份:
    2019
  • 资助金额:
    $ 30.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Assessment and treatment of acute renal failure targetting free-heme in rhabdomyolysis
横纹肌溶解症中针对游离血红素的急性肾衰竭的评估和治疗
  • 批准号:
    19K09424
  • 财政年份:
    2019
  • 资助金额:
    $ 30.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of Ca channels and KV1.3 channels in chronic renal failure and the development of preventive therapy against septic acute renal failure progressing to chronic hemodialysis
Ca通道和KV1.3通道在慢性肾功能衰竭中的作用以及脓毒症急性肾功能衰竭进展为慢性血液透析的预防治疗的发展
  • 批准号:
    16K20079
  • 财政年份:
    2016
  • 资助金额:
    $ 30.31万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Immunomodulatory Device for Treatment of Pediatric Acute Renal Failure Patients
用于治疗小儿急性肾衰竭患者的免疫调节装置
  • 批准号:
    8453029
  • 财政年份:
    2013
  • 资助金额:
    $ 30.31万
  • 项目类别:
Dose optimization of the central nervous system acting compound considering its altered pharmacokinetics and pharmacodynamics in patients with acute renal failure
考虑到急性肾衰竭患者药代动力学和药效学的改变,中枢神经系统作用化合物的剂量优化
  • 批准号:
    24590192
  • 财政年份:
    2012
  • 资助金额:
    $ 30.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effect of mesenchymal stem cells on septic acute renal failure
间充质干细胞对脓毒症急性肾功能衰竭的治疗作用
  • 批准号:
    24592756
  • 财政年份:
    2012
  • 资助金额:
    $ 30.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of a novel pathogen sensor in the pathophysiology of acute renal failure
新型病原体传感器在急性肾衰竭病理生理学中的作用
  • 批准号:
    23659440
  • 财政年份:
    2011
  • 资助金额:
    $ 30.31万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Amelioration of Acute Tubular Necrosis in Ischemic Acute Renal Failure was Impaired in Mice Lucking Hypoxia Inducible Factor-1α Gene
幸运缺氧诱导因子1α基因对缺血性急性肾衰竭小鼠急性肾小管坏死的改善作用
  • 批准号:
    23791759
  • 财政年份:
    2011
  • 资助金额:
    $ 30.31万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Endothelial Injury in Endotoxin-Induced Acute Renal Failure
内毒素引起的急性肾衰竭中的内皮损伤
  • 批准号:
    7785146
  • 财政年份:
    2010
  • 资助金额:
    $ 30.31万
  • 项目类别:
Acute Renal Failure: An Endotoxin Hyper-Responsive State
急性肾衰竭:内毒素高反应状态
  • 批准号:
    8118789
  • 财政年份:
    2010
  • 资助金额:
    $ 30.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了